Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Neus Pagès"'
Autor:
José Miguel Sotoca-Momblona, Montserrat Rodriguez-Reyes, Neus Pagès-Puigdemont, Concepció Bartres-Viñas, Sergio Rodriguez-Tajes, Sabela Lens-García, Zoe Mariño-Mendez
Publikováno v:
Ars Pharmaceutica, Vol 61, Iss 1, Pp 45-47 (2020)
RESUMEN Objetivos: Determinar la efectividad del tratamiento de la hepatitis C crónica definida como la respuesta viral sostenida a las 12 semanas (RVS12) tras la finalización del tratamiento con fármacos antivirales de acción directa (AAD) (glec
Externí odkaz:
https://doaj.org/article/681c38ef8530431787c41ed01fa0dca2
Proteins work only if folded in their native state, but changes in temperature T and pressure P induce their unfolding. Therefore for each protein there is a stability region (SR) in the T-P thermodynamic plane outside which the biomolecule is denatu
Externí odkaz:
http://arxiv.org/abs/1704.03370
Publikováno v:
Ars Pharmaceutica, Vol 59, Iss 3, Pp 163-172
RESUMEN Objetivos: Describir cuáles son los principales métodos para medir la adherencia terapéutica de los pacientes y determinar los más idóneos para ser utilizados en la práctica clínica diaria de la Farmacia Comunitaria. Métodos: Se reali
Externí odkaz:
https://doaj.org/article/7dca75ccb2404ac2896ded3c1d7c7f31
Publikováno v:
Ars Pharmaceutica, Vol 59, Iss 4, Pp 251-258
RESUMEN Objetivos: Describir los factores que pueden influir en la adherencia a los tratamientos farmacológicos y las intervenciones que han sido desarrolladas para su mejora. Métodos: Se realizó una búsqueda de los artículos de investigación m
Externí odkaz:
https://doaj.org/article/8a0632bc5c1f41f7bd344a656f7c42a9
Autor:
Anna, De Dios, Montserrat, Masip, Neus, Pagès-Puigdemont, Pau, Riera, María, Gracia Mateo, María Del Mar, Gutiérrez, Maria Antònia, Mangues, Mar, Gomis-Pastor
Publikováno v:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 46(7)
People living with human immunodeficiency virus could particularly benefit from mobile health (mHealth). The objective of the study was to contribute to the design and development of a new standard of care for people living with human immunodeficienc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::14a9148b159799dc33a028561a8e5aed
https://pubmed.ncbi.nlm.nih.gov/36520560
https://pubmed.ncbi.nlm.nih.gov/36520560
Autor:
Josep Miquel Sotoca-Momblona, Marina Rovira-Illamola, Mireia Mensa-Vendrell, Mercè Casasayas-Guilera, Neus Pagès-Puigdemont, Olga Barba-Ávila
Publikováno v:
International Journal of Clinical Pharmacy. 42:737-743
Background Olmesartan, an antihypertensive drug, has been associated with a severe and potentially life-threatening sprue-like enteropathy, consisting of a serious, chronic diarrhoea and malabsorption syndrome. Treatment with this drug should be disc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::445f605a77306b5d726363d0ba4caa5a
https://doi.org/10.1007/s11096-020-00993-7
https://doi.org/10.1007/s11096-020-00993-7
Autor:
David Medina-Catalán, Pau Riera, Neus Pagès-Puigdemont, Montserrat Masip, Anna López-Ferrer, Eva Vilarrasa, Lluís Puig
Publikováno v:
International Journal of Clinical Pharmacy
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Background Guselkumab is indicated for moderate-to-severe plaque psoriasis. Data from real-life clinical practice regarding its use are scarce, especially concerning patients who relapse after previous biologic therapies. Aim This study aimed to eval
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d984b24c73cbc1a4ee50ec572dddc964
https://pubmed.ncbi.nlm.nih.gov/35380392
https://pubmed.ncbi.nlm.nih.gov/35380392
Autor:
Montserrat Masip, Teresa Puig, Laura Tuneu, Maria Antonia Mangues, Neus Pagès-Puigdemont, Pere Valls
Publikováno v:
EUROPEAN JOURNAL OF PUBLIC HEALTH
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Background Medication adherence is a complex area of behaviour. Little is known about what influences chronic patients to take their medicines. This study has aimed to compare and contrast the health-related beliefs, experiences and types of behaviou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3bb1aef039ddf27e93ee5ffcc90a79d
https://doi.org/10.1093/eurpub/cky259
https://doi.org/10.1093/eurpub/cky259
Autor:
Adolfo Gallego, José A. Carrión, Xavier Torras, Rosa Maria Morillas, E González-Colominas, Sergi Mojal, María-Carlota Londoño, Neus Pagès, Zoe Mariño, Mercè Ardèvol, Ricard Solà, Dulce López, Sabela Lens
Publikováno v:
Journal of Gastroenterology and Hepatology. 33:1100-1107
Background & Aims Drug-drug interactions (DDIs) with ombitasvir/paritaprevir/ritonavir with or without dasabuvir and with or without ribavirin (OBV/PTV/r ± DSV ± RBV) are common in clinical trials. Our aim was to analyze the prevalence and manageme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::77990c67f35c7cc82eba0f7b9dfa939d
https://doi.org/10.1111/jgh.14014
https://doi.org/10.1111/jgh.14014
Autor:
M Sans, Dolors Soy, M Rovira-Illamola, E Martínez, M Ortega, L Gené, A Silva, Neus Pagès-Puigdemont, A Lascorz, I Garrell, L GUerrero
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background Frail and multimorbid patients are often prescribed multiple medications.1 Polypharmacy, along with drug-drug interactions and potentially inappropriate medications (PIMs), are known as the iatrogenic triad. Consequently, this population h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c71d440fd0126d1f8f676b2d0c10f6e8
https://doi.org/10.1136/ejhpharm-2019-eahpconf.400
https://doi.org/10.1136/ejhpharm-2019-eahpconf.400